09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Related
Governor Gavin Newsom just signed into law two amendments to the California Consumer Privacy Act (CC...
Read More >
On January 3, 2020, Puerto Rico Governor Wanda Vázquez signed Law No. 9-2020 (“Act 9” or “the Act...
Read More >
Leading Retailer Failed to Reasonably Accommodate Deaf Employees Federal Agency Charged - WASHINGT...
Read More >
On June 14, 2019, the Southern District of New York declined to certify a consumer fraud class actio...
Read More >
Welcome to the thirteenth survey of sponsor-backed going private transactions prepared by Weil, Gots...
Read More >
Statutory body: Foreign Investment Review Board Website: www.firb.gov.au Australia’s Foreign Invest...
Read More >